国家: 澳大利亚
语言: 英文
来源: APVMA (Australian Pesticides and Veterinary Medicines Authority)
STREPTOCOCCUS UBERIS ANTIGEN; MONTANIDE ISA 201 VG; MONOPHOSPHORYL LIPID A (MPLA)
LABORATORIOS HIPRA S.A.
PARENTERAL LIQUID/SOLUTION/SUSPENSION
STREPTOCOCCUS UBERIS ANTIGEN VACCINE-ANTIGEN Active 0.0 P; MONTANIDE ISA 201 VG Other 0.0 P; MONOPHOSPHORYL LIPID A (MPLA) Other 0.0 P
10 mL; 100 mL; 20 x 2 mL; 50 mL
VM - Veterinary Medicine
IMMUNOTHERAPY
Poison schedule: 0; Withholding period: Zero (0) days. EXPORT SLAUGHTER INTERVA L (ESI): Zero (0) days. Before using thi s product, confirm the current ESI from the distributor on 02 8088 0720 or the A PVMA website (apvma.gov.au/residues).; Host/pest details: CATTLE: [CLINICAL INTRAMAMMARY INFECTIONS, STREPTOCOCCUS UBERIS]
Registered
2024-02-06
One dose (2 mL) contains: Lipoteichoic acid (LTA) from Biofilm Adhesion Component (BAC) of Streptococcus uberis, strain 5616 ≥ 1 Relative Potency Units (ELISA) Also contains: Montanide ISA (adjuvant) Monophosphoryl Lipid A (adjuvant) Constituent Statements: For active immunisation of healthy cows and heifers to reduce the incidence of clinical intramammary infections caused by Streptococcus uberis, to reduce the somatic cell count in Streptococcus uberis positive quarter milk samples and to reduce milk production losses caused by Streptococcus uberis intramammary infections. Onset of immunity: approximately 36 days after the second dose. Duration of immunity: approximately the first 5 months of lactation. Claims: 20 x 2 mL, 10 mL, 50 mL, 100 mL Net Contents: Directions for Use: Restraints: READ SAFETY DIRECTIONS FOR ANIMAL TREATMENT ONLY Signal Headings: UBAC Inactivated Subunit Vaccine against Streptococcus uberis for Cattle Label Name: Contraindications: Precautions: Only healthy animals should be immunised. The whole herd should be immunised. Protection of animals not vaccinated according to this program has not been demonstrated. UBAC Inactivated Subunit Vaccine against Streptococcus uberis for Cattle 92734/136470 Product Name: APVMA Approval No: RLP APPROVED Local swelling more than 5 cm in diameter at the injection site is a very common reaction after administration of the vaccine. This swelling will have disappeared or be clearly reduced in size by 17 days post vaccination. However, in some cases, swelling may persist for up to 4 weeks. A transient increase in rectal temperature (mean increase of 1°C but may be up to 2°C in individual animals) commonly occur in the first 24 hours after injection. Anaphylactic-type reactions (e.g. oedema) which might be life-threatening, may occur very rarely in some sensitive animals based on post-marketing safety experience. Under these circumstances, appropriate symptomatic treatment should be administered. The frequency of adverse reaction is defined using the follo 阅读完整的文件